Werewolf Therapeutics, Inc.
HOWL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$70,515 | -$37,368 | -$53,810 | -$49,983 |
| Dep. & Amort. | $1,814 | $1,764 | $1,104 | $216 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,826 | $8,008 | $7,400 | $4,095 |
| Change in WC | $2,526 | -$5,894 | $2,539 | $2,277 |
| Other Non-Cash | $1,161 | $878 | $2,171 | $519 |
| Operating Cash Flow | -$56,188 | -$32,612 | -$40,596 | -$42,876 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$254 | -$769 | -$3,611 | -$498 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$254 | -$769 | -$3,611 | -$498 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10,000 | $40,000 | $0 | $0 |
| Stock Issued | $23,576 | $18,329 | $15,740 | $111,600 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$496 | $100 | $166 | -$2,173 |
| Financing Cash Flow | $13,080 | $58,429 | $15,906 | $109,427 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$43,362 | $25,048 | -$28,301 | $66,053 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $155,577 | $130,529 | $158,830 | $92,777 |
| End Cash | $112,215 | $155,577 | $130,529 | $158,830 |
| Free Cash Flow | -$56,442 | -$33,381 | -$44,207 | -$43,374 |